Scarlett v. Belair Insurance Co. : A 2015 Update on the MIG
In this 2015 appeal[1] by Mr. Scarlett to the Divisional Court, Director Delegate Evans’ decision was partially upheld. First, the Divisional Court clearly found that the injured person has the burden of proving that his or her injuries fall outside of the Minor Injuries Guideline (“MIG”). S…
View the post titled Scarlett v. Belair Insurance Co. : A 2015 Update on the MIGRemoving a Court-Appointed Guardian in Ontario
Previous articles have discussed powers of attorney and guardianships and the duties and obligations of attorneys and guardians. But what can be done when a family member of the incapable person feels that the guardian or attorney is not acting appropriately? Occasionally, supportive friends…
View the post titled Removing a Court-Appointed Guardian in OntarioToronto Mulls Administrative Monetary Penalty System
As cities aim to improve their sustainability, by improving air quality and congestion, the City of Toronto is looking at ways to make it easier to ticket cars blocking bike lanes by moving to an Administrative Monetary Penalty (AMP) system. And to save some money in the process. We weren’t …
View the post titled Toronto Mulls Administrative Monetary Penalty SystemThe Paris Agreement
Over the weekend, representatives from 195 countries signed an historic agreement aimed at curbing climate change. The “Paris Agreement,” which has yet, of course, to be ratified, is being touted as a “universal” climate agreement, with 195 signatories. Industry, poli…
View the post titled The Paris AgreementZofran: A Drug Manufacturer’s Duty to Warn
The Class Actions team at Siskinds LLP recently commenced a new case against the pharmaceutical manufacturers of Zofran. The class action claim alleges that the drug manufacturers failed to warn that Zofran is unsafe for pregnant women. In Canada, drug manufacturers have a duty to warn of th…
View the post titled Zofran: A Drug Manufacturer’s Duty to WarnZofran: The Dangers of Off-Label Drug Use
The Class Actions team at Siskinds LLP recently commenced a new case against the pharmaceutical manufacturers of Zofran. The class action claim alleges that the drug manufacturers failed to warn that off-label use of Zofran is unsafe for pregnant women. Zofran is a powerful anti-nausea medic…
View the post titled Zofran: The Dangers of Off-Label Drug UseFurther momentum on cap and trade
The Ontario government announced earlier this week the signing of an MOU between Ontario, Quebec, and Manitoba to link their respective cap and trade programmes. The agreement was signed while the Premiers of the three provinces were participating in the Paris Conference on Climate change (C…
View the post titled Further momentum on cap and tradeFurther momentum on cap and trade
The Ontario government announced earlier this week the signing of an MOU between Ontario, Quebec, and Manitoba to link their respective cap and trade programmes. The agreement was signed while the Premiers of the three provinces were participating in the Paris Conference on Climate change (C…
View the post titled Further momentum on cap and tradeBird-building collisions and ECAs
The Ministry of the Environment and Climate Change (“MOECC”) has posted to the Environmental Registry (“ER”) a proposal for a draft regulatory amendment to exempt reflective building surfaces (such as the windows of office buildings) from requiring an Environmental C…
View the post titled Bird-building collisions and ECAsAvis Favaro of CTV News Interviews Jill McCartney of Siskinds LLP regarding Zofran Class Action
The Class Actions team at Siskinds LLP recently commenced a new case against the pharmaceutical manufacturers of Zofran. The class action claim alleges that the drug manufacturers failed to warn that Zofran was unsafe for pregnant women. Zofran is a powerful anti-nausea medication approved b…
View the post titled Avis Favaro of CTV News Interviews Jill McCartney of Siskinds LLP regarding Zofran Class ActionReceive Blog Posts
By subscribing to our blog, you will receive an email when a new post is added. You can unsubscribe at any time by sending an email to us at [email protected] with the word “unsubscribe” in the subject line.